Breakthrough Research
City of Hope is recognized internationally for its breakthrough research discoveries and clinical trials for novel new agents to treat multiple myeloma. We are the only Southern California member of the multiple Myeloma Research Consortium, a collaboration of the most prestigious research organizations focused on bringing promising new multiple myeloma treatments to patients.
 
City of Hope has long been a leader in developing promising new combinations of chemotherapy drugs, stem cell transplant procedures and radiation treatments. Current efforts include development of immunotherapy drugs, and we are one of the few institutions to begin T cell trials. With our extensive program of clinical trials, City of Hope can provide our patients access to novel therapies not yet available elsewhere.
 
For patients with relapsed myeloma, multiple treatment options are available, including both standard drugs and novel agents that are being tested in clinical trials.
 
To learn more about our clinical trials program,  click here.